{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:09:30Z","timestamp":1792084170422,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Louis Ng Foundation","award":["NHK17EG01"],"award-info":[{"award-number":["NHK17EG01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Global implementation of gastric cancer (GC) screening in chronic dyspepsia populations faces challenges due to the high number-needed-to-scope (NNS) for oesophagogastroduodenoscopy. Routine blood tests (RBT) have limited utility for GC screening but offer potential for risk stratification when repurposed through machine learning. This study develops and validates a machine-learning-integrated biomarker (RBT-GC) that uses opportunistic triage to optimise endoscopy resource allocation. The team analysed 20 years of territory-wide retrospective data (2000\u20132020) from the Hong Kong Hospital Authority. 24 RBT and demographic features from 210,463 subjects (3071 cases) between 2000 and 2015 were used in training. An independent cohort of 90,479 subjects (2066 cases) from 2016 to 2020 was used in validation. The RBT-GC model successfully stratified validation cohort (2.3% baseline GC prevalence) into low-risk (0.3% prevalence), intermediate-risk (1.9%) and high-risk (14.0%) categories. The model detected (1276 cases) 12x more than CEA (102 cases) and 30x more than CA19.9 (42 cases). The application of opportunistic RBT-GC risk stratification reduced the NNS from 44 to 7 in the high-risk category of validation cohort. This machine learning approach repurposed standard blood tests into an opportunistic, affordable, scalable triage tool to alleviate endoscopic burdens across healthcare systems.<\/jats:p>","DOI":"10.1038\/s41746-026-02618-1","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:17:16Z","timestamp":1776406636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a novel blood-based biomarker for gastric cancer triage in chronic dyspepsia"],"prefix":"10.1038","volume":"9","author":[{"given":"Minji","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Man","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene J. L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Y. M.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie W. Y.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C. H.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada S. M.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen K. K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S. C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry H. W.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy M. Y.","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sau Shan","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry H. Y.","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C. C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2618_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"2618_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-025-01698-y","volume":"18","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis. J. Hematol. Oncol. 18, 42 (2025).","journal-title":"J. Hematol. Oncol."},{"key":"2618_CR3","doi-asserted-by":"publisher","first-page":"107327482210992","DOI":"10.1177\/10732748221099227","volume":"29","author":"Y Li","year":"2022","unstructured":"Li, Y., Feng, A., Zheng, S., Chen, C. & Lyu, J. Recent estimates and predictions of 5-year survival in patients with gastric cancer: a model-based period analysis. Cancer Control 29, 10732748221099227 (2022).","journal-title":"Cancer Control"},{"key":"2618_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick, F. et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 1005\u20131020 (2022).","journal-title":"Ann. Oncol."},{"key":"2618_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani, J. A. et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 20, 167\u2013192 (2022).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"2618_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/jjco\/hyy077","volume":"48","author":"C Hamashima","year":"2018","unstructured":"Hamashima, C. Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines. Update version of the Japanese guidelines for gastric cancer screening. Jpn. J. Clin. Oncol. 48, 673\u2013683 (2018).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"2618_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.12703\/r\/12-17","volume":"12","author":"V Namasivayam","year":"2023","unstructured":"Namasivayam, V. Endoscopic screening and surveillance for gastric cancer: challenges and opportunities. Fac. Rev. 12, 17 (2023).","journal-title":"Fac. Rev."},{"key":"2618_CR8","doi-asserted-by":"publisher","first-page":"e240007","DOI":"10.1001\/jamanetworkopen.2024.0007","volume":"7","author":"FE Juul","year":"2024","unstructured":"Juul, F. E. et al. Effectiveness of colonoscopy screening vs sigmoidoscopy screening in colorectal cancer. JAMA Netw. open 7, e240007\u2013e240007 (2024).","journal-title":"JAMA Netw. open"},{"key":"2618_CR9","unstructured":"GovHK. Eligibility of Colorectal Cancer Screening Programme Updated (The Government of the Hong Kong Special Administrative Region, 2022)."},{"key":"2618_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejca.2023.01.011","volume":"182","author":"E Nemlander","year":"2023","unstructured":"Nemlander, E. et al. A machine learning tool for identifying non-metastatic colorectal cancer in primary care. Eur. J. Cancer 182, 100\u2013106 (2023).","journal-title":"Eur. J. Cancer"},{"key":"2618_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2183\/pjab.87.405","volume":"87","author":"K Miki","year":"2011","unstructured":"Miki, K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels\u2014\u201cABC method\u201d. Proc. Jpn. Acad. Ser. B 87, 405\u2013414 (2011).","journal-title":"Proc. Jpn. Acad. Ser. B"},{"key":"2618_CR12","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1136\/gutjnl-2018-317556","volume":"68","author":"Q Cai","year":"2019","unstructured":"Cai, Q. et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut 68, 1576\u20131587 (2019).","journal-title":"Gut"},{"key":"2618_CR13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/apt.16272","volume":"53","author":"WK Leung","year":"2021","unstructured":"Leung, W. K., Cheung, K. S., Li, B., Law, S. Y. & Lui, T. K. Applications of machine learning models in the prediction of gastric cancer risk in patients after Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 53, 864\u2013872 (2021).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2618_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01480-x","volume":"8","author":"K Ishizu","year":"2025","unstructured":"Ishizu, K. et al. Establishment of a machine learning model for predicting splenic hilar lymph node metastasis. npj Digit. Med. 8, 93 (2025).","journal-title":"npj Digit. Med."},{"key":"2618_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2020-322065","volume":"70","author":"JBY So","year":"2021","unstructured":"So, J. B. Y. et al. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. Gut 70, 829\u2013837 (2021).","journal-title":"Gut"},{"key":"2618_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5114\/pg.2019.88167","volume":"14","author":"E Aksoy","year":"2019","unstructured":"Aksoy, E. et al. The importance of complete blood count parameters in the screening of gastric cancer. Gastroenterol. Rev.\/Prz. Gastroenterol. 14, 183\u2013187 (2019).","journal-title":"Gastroenterol. Rev.\/Prz. Gastroenterol."},{"key":"2618_CR17","doi-asserted-by":"crossref","unstructured":"Cheung, K. M. et al. The identification of blood pattern for gastric cancer from routine blood tests in a territory-wide big clinical database. J. Clin. Oncol. 41, e13584 (2023).","DOI":"10.1200\/JCO.2023.41.16_suppl.e13584"},{"key":"2618_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301541","volume":"19","author":"S Uddin","year":"2024","unstructured":"Uddin, S. & Lu, H. Confirming the statistically significant superiority of tree-based machine learning algorithms over their counterparts for tabular data. PLoS ONE 19, e0301541 (2024).","journal-title":"PLoS ONE"},{"key":"2618_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00441-023-03816-z","volume":"394","author":"S Ng","year":"2023","unstructured":"Ng, S., Masarone, S., Watson, D. & Barnes, M. R. The benefits and pitfalls of machine learning for biomarker discovery. Cell tissue Res. 394, 17\u201331 (2023).","journal-title":"Cell tissue Res."},{"key":"2618_CR20","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/cancers15051399","volume":"15","author":"AJ Read","year":"2023","unstructured":"Read, A. J., Zhou, W., Saini, S. D., Zhu, J. & Waljee, A. K. Prediction of gastrointestinal tract cancers using longitudinal electronic health record data. Cancers 15, 1399 (2023).","journal-title":"Cancers"},{"key":"2618_CR21","doi-asserted-by":"crossref","unstructured":"Park, B. et al. A machine learning risk prediction model for gastric cancer with SHapley Additive exPlanations. Cancer Res. Treat. 57, 821\u2013829 (2024).","DOI":"10.4143\/crt.2024.843"},{"key":"2618_CR22","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.3390\/cancers16132353","volume":"16","author":"D Lewis","year":"2024","unstructured":"Lewis, D., Jimenez, L., Mansour, M. H., Horton, S. & Wong, W. W. A systematic review of cost-effectiveness studies on gastric cancer screening. Cancers 16, 2353 (2024).","journal-title":"Cancers"},{"key":"2618_CR23","unstructured":"Bank, T. W. World Development Indicators (The World Bank Group, 2024)."},{"key":"2618_CR24","doi-asserted-by":"publisher","first-page":"8146","DOI":"10.18410\/jebmh\/2015\/1095","volume":"2","author":"S Barve","year":"2015","unstructured":"Barve, S., Patel, D., Shiromani, K. & Jawarkar, A. Role of RBC count and RBC indices in diagnosing and differentiating anemias caused due to various clinical situations in a tertiary care hospital in Vadodara, Gujarat. J. Evid. Based Med. Healthc. 2, 8146\u20138148 (2015).","journal-title":"J. Evid. Based Med. Healthc."},{"key":"2618_CR25","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/gutjnl-2022-327737","volume":"71","author":"CJ Black","year":"2022","unstructured":"Black, C. J. et al. British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut 71, 1697\u20131723 (2022).","journal-title":"Gut"},{"key":"2618_CR26","doi-asserted-by":"publisher","first-page":"e23268","DOI":"10.1002\/jcla.23268","volume":"34","author":"X Gong","year":"2020","unstructured":"Gong, X. & Zhang, H. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer. J. Clin. Lab. Anal. 34, e23268 (2020).","journal-title":"J. Clin. Lab. Anal."},{"key":"2618_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48769-y","volume":"9","author":"J Taninaga","year":"2019","unstructured":"Taninaga, J. et al. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: a case-control study. Sci. Rep. 9, 12384 (2019).","journal-title":"Sci. Rep."},{"key":"2618_CR28","doi-asserted-by":"publisher","first-page":"e0144","DOI":"10.1097\/MD.0000000000010144","volume":"97","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer. Medicine 97, e0144 (2018).","journal-title":"Medicine"},{"key":"2618_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.4251\/wjgo.v14.i5.1002","volume":"14","author":"Y-T Li","year":"2022","unstructured":"Li, Y.-T. et al. Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer. World J. Gastrointest. Oncol. 14, 1002 (2022).","journal-title":"World J. Gastrointest. Oncol."},{"key":"2618_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/549843","volume":"2015","author":"Y-x Song","year":"2015","unstructured":"Song, Y. -x et al. Clinicopathologic and prognostic value of serum carbohydrate antigen 19-9 in gastric cancer: A meta-analysis. Dis. Markers 2015, 549843 (2015).","journal-title":"Dis. Markers"},{"key":"2618_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75319-8","volume":"10","author":"M Sekiguchi","year":"2020","unstructured":"Sekiguchi, M. & Matsuda, T. Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening. Sci. Rep. 10, 18202 (2020).","journal-title":"Sci. Rep."},{"key":"2618_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/1096-9098(200007)74:3<185::AID-JSO4>3.0.CO;2-0","volume":"74","author":"DY Kim","year":"2000","unstructured":"Kim, D. Y. et al. Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients. J. Surg. Oncol. 74, 185\u2013192 (2000).","journal-title":"J. Surg. Oncol."},{"key":"2618_CR33","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.7314\/APJCP.2013.14.7.4289","volume":"14","author":"A Sisik","year":"2013","unstructured":"Sisik, A., Kaya, M., Bas, G., Basak, F. & Alimoglu, O. CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Asian Pac. J. Cancer Prev. 14, 4289\u20134294 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"2618_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.21147\/j.issn.1000-9604.2021.06.02","volume":"33","author":"R Zhou","year":"2021","unstructured":"Zhou, R. et al. Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations. Chin. J. Cancer Res. 33, 649 (2021).","journal-title":"Chin. J. Cancer Res."},{"key":"2618_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03123-z","volume":"24","author":"K Gohari","year":"2024","unstructured":"Gohari, K. et al. Development of a gastric cancer risk calculator for questionnaire-based surveillance of Iranian dyspeptic patients. BMC Gastroenterol. 24, 39 (2024).","journal-title":"BMC Gastroenterol."},{"key":"2618_CR36","doi-asserted-by":"publisher","first-page":"49565","DOI":"10.18632\/oncotarget.10391","volume":"7","author":"Y Liang","year":"2016","unstructured":"Liang, Y. et al. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Oncotarget 7, 49565 (2016).","journal-title":"Oncotarget"},{"key":"2618_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12029-016-9912-7","volume":"49","author":"J Yu","year":"2018","unstructured":"Yu, J. & Zheng, W. An alternative method for screening gastric cancer based on serum levels of CEA, CA19-9, and CA72-4. J. Gastrointest. Cancer 49, 57\u201362 (2018).","journal-title":"J. Gastrointest. Cancer"},{"key":"2618_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02315-9","volume":"22","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q., Chen, Y., Pan, J., Zhou, L. & Lin, J. Application of a novel scoring system for gastric cancer opportunistic screening in hospital visits. BMC Gastroenterol. 22, 223 (2022).","journal-title":"BMC Gastroenterol."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02618-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02618-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02618-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:08:16Z","timestamp":1781651296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02618-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2618"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02618-1","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"466"}}